Gastric Adenocarcinoma Recruiting Phase 1 Trials for Oxaliplatin (DB00526)

Back to Gastric Adenocarcinoma

Also known as: Adenocarcinoma gastric / Adenocarcinoma, Gastric / Gastric Adenocarcinomas / Adenocarcinoma of the Stomach / Stomach Adenocarcinoma / Gastric Cancer, Adenocarcinoma / Adenocarcinoma of stomach (disorder)

Indication	Status	Phase
DBCOND0030814 (Gastric Adenocarcinoma)	Recruiting	1

clinicaltrials.gov Identifier	Title	Purpose	Drugs
NCT05365581	A Study of ASP2138 Given by Itself or Given With Other Cancer Treatments in Adults With Stomach Cancer, Gastroesophageal Junction Cancer, or Pancreatic Cancer	Treatment	ASP-2138 (DB18473) Fluorouracil (DB00544) Irinotecan (DB00762) Leucovorin (DB00650) Oxaliplatin (DB00526) Paclitaxel (DB01229) Pembrolizumab (DB09037) Ramucirumab (DB05578)
NCT05802056	Aldesleukin With Nivolumab and Standard Chemotherapy for Treatment of Gastric Cancer With Peritoneal Metastasis	Treatment	Aldesleukin (DB00041) Calcium (DB01373) Fluorouracil (DB00544) Leucovorin (DB00650) Levoleucovorin (DB11596) Nivolumab (DB09035) Oxaliplatin (DB00526)